Ledger.Open graph →
SEC Form D · Amendment · filed August 9, 2021

Tempo Therapeutics, Inc

Offering
$3.9M
Sold
$3.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Westbrook Weaver · San Diego, CAExec · Director · PromoterRichard Hancock · San Diego, CADirectorSteven Richieri · San Diego, CAExec · DirectorDino Di Carlo · San Diego, CADirectorDonald Griffin · San Diego, CADirectorDavid P. Fialkow · CAMBRIDGE, MAExec · DirectorPaul Lammers, Md, Msc · AUSTIN, TXExec · Director · PromoterJoel E. Cutler · CAMBRIDGE, MADirectorNarasimha Polkampally · Plainsboro, NJDirectorScott M. Smith · AUSTIN, TXDirectorJames Liu · New York, NYExec · DirectorSame Zadig Capital GP LLC · New York, NYDirectorSame Zadig Capital Management LLC · New York, NYDirectorMichael A. Liang · St. Louis Park, MNDirectorKirk Avery · Austin, TXExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗